Controlled selection of oxytetracycline-resistant cells ofEscherichia coli in minimal media

1968 ◽  
Vol 8 (2) ◽  
pp. 151-153 ◽  
Author(s):  
V. Krčméry ◽  
E. Parrakova ◽  
M. Pappova
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yağmur Demircan Yalçın ◽  
Taylan Berkin Töral ◽  
Sertan Sukas ◽  
Ender Yıldırım ◽  
Özge Zorlu ◽  
...  

AbstractWe report the development of a lab-on-a-chip system, that facilitates coupled dielectrophoretic detection (DEP-D) and impedimetric counting (IM-C), for investigating drug resistance in K562 and CCRF-CEM leukemia cells without (immuno) labeling. Two IM-C units were placed upstream and downstream of the DEP-D unit for enumeration, respectively, before and after the cells were treated in DEP-D unit, where the difference in cell count gave the total number of trapped cells based on their DEP characteristics. Conductivity of the running buffer was matched the conductivity of cytoplasm of wild type K562 and CCRF-CEM cells. Results showed that DEP responses of drug resistant and wild type K562 cells were statistically discriminative (at p = 0.05 level) at 200 mS/m buffer conductivity and at 8.6 MHz working frequency of DEP-D unit. For CCRF-CEM cells, conductivity and frequency values were 160 mS/m and 6.2 MHz, respectively. Our approach enabled discrimination of resistant cells in a group by setting up a threshold provided by the conductivity of running buffer. Subsequent selection of drug resistant cells can be applied to investigate variations in gene expressions and occurrence of mutations related to drug resistance.


1983 ◽  
Vol 64 (5) ◽  
pp. 1101-1110 ◽  
Author(s):  
A. Chiarini ◽  
S. Arista ◽  
A. Giammanco ◽  
A. Sinatra

2003 ◽  
Vol 279 (10) ◽  
pp. 9215-9221 ◽  
Author(s):  
Zheng Dong ◽  
Jinzhao Wang
Keyword(s):  

1998 ◽  
Vol 273 (33) ◽  
pp. 20779-20784 ◽  
Author(s):  
Chiara Bovolenta ◽  
Lucia Testolin ◽  
Luisa Benussi ◽  
Patricia M.-J. Lievens ◽  
Elio Liboi

Evolution ◽  
1993 ◽  
Vol 47 (3) ◽  
pp. 741-749 ◽  
Author(s):  
Pedro J. N. Silva ◽  
Daniel E. Dykhuizen

Genetics ◽  
1975 ◽  
Vol 80 (1) ◽  
pp. 157-169
Author(s):  
B C Myhr ◽  
J A DiPaolo

ABSTRACT With V79 Chinese hamster cell cultures treated with a mutagen, the maximum frequency of colonies resistant to 8-azaguanine (AZG) was attained when the cells were dispersed after a suitable expression time before adding the selection medium. V79–4 cells were exposed to 500 µM MMS, 7 µM AFAA, or 10 µM MNNG and allowed to multiply before being reseeded at 4 × 104 cells/60 mm dish and selected with 10 µg/ml AZG. Maximum frequencies of 4 × 10-5, 4 × 10-4, and 2.4 × 10-3 were obtained about 100, 130, and 200 hrs after exposure to MMS, AFAA, and MNNG, respectively. The maximum frequencies following MMS or MNNG treatments were about 10-fold greater than those obtained when induction and selection of AZG-resistant colonies were performed in the same culture dish. The reseeding of treated cells eliminated the possibility of metabolic cooperation within mosaic colonies of wild-type and mutant cells and achieved expression of the induced changes before intercolony crossfeeding reduced the frequency of resistant colonies.—AZG-resistant colonies were selected in medium containing dialyzed fetal bovine serum, and the selection medium was replaced at least twice. Both serum dialysis and selection medium replacement were necessary for consistent achievement of background frequencies of resistant colonies near 10-6. Reconstruction experiments with AZG-resistant V79 lines showed that the efficiency of recovery of resistant cells in the selection medium was constant over a range of 0–20 colonies observed/dish. A mixed population of V79 and AZG-resistant cells was also correctly analyzed by the procedure used in mutagenesis studies.


Cancers ◽  
2018 ◽  
Vol 10 (10) ◽  
pp. 365 ◽  
Author(s):  
Maxim Sorokin ◽  
Roman Kholodenko ◽  
Maria Suntsova ◽  
Galina Malakhova ◽  
Andrew Garazha ◽  
...  

Sequential courses of anticancer target therapy lead to selection of drug-resistant cells, which results in continuous decrease of clinical response. Here we present a new approach for predicting effective combinations of target drugs, which act in a synergistic manner. Synergistic combinations of drugs may prevent or postpone acquired resistance, thus increasing treatment efficiency. We cultured human ovarian carcinoma SKOV-3 and neuroblastoma NGP-127 cancer cell lines in the presence of Tyrosine Kinase Inhibitors (Pazopanib, Sorafenib, and Sunitinib) and Rapalogues (Temsirolimus and Everolimus) for four months and obtained cell lines demonstrating increased drug resistance. We investigated gene expression profiles of intact and resistant cells by microarrays and analyzed alterations in 378 cancer-related signaling pathways using the bioinformatical platform Oncobox. This revealed numerous pathways linked with development of drug resistant phenotypes. Our approach is based on targeting proteins involved in as many as possible signaling pathways upregulated in resistant cells. We tested 13 combinations of drugs and/or selective inhibitors predicted by Oncobox and 10 random combinations. Synergy scores for Oncobox predictions were significantly higher than for randomly selected drug combinations. Thus, the proposed approach significantly outperforms random selection of drugs and can be adopted to enhance discovery of new synergistic combinations of anticancer target drugs.


Sign in / Sign up

Export Citation Format

Share Document